Ackermann, Jean et al. published their patent in 2011 |CAS: 1262988-77-1

The Article related to piperidinecarboxamide preparation hormone sensitive lipase hsl inhibitor treatment disease, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.HPLC of Formula: 1262988-77-1

On February 3, 2011, Ackermann, Jean; Conte, Aurelia; Hunziker, Daniel; Neidhart, Werner; Nettekoven, Matthias; Wertheimer, Stanley published a patent.HPLC of Formula: 1262988-77-1 The title of the patent was Piperidine-4-carboxamide derivatives as hormone sensitive lipase (HSL) inhibitors and their preparation and use for the treatment of diseases. And the patent contained the following:

The invention relates to piperidine-4-carboxamide derivatives of formula I, which are hormone sensitive lipase (HSL) inhibitors and which are useful in the treatment of diseases. Compounds of formula I wherein R1 is alkyl, cycloalkyl, haloalkyl, etc.; R2 is H, alkyl and cycloalkyl; R3 is (un)substituted indanyl, (un)substituted pyridinyl, (un)substituted pyrimidyl, etc.; R4 is H, alkyl and cycloalkyl; A1 is carbonyl, SO2, NHCO, etc.; A2 is O and NH and derivatives; and pharmaceutically acceptable salts thereof, are claimed. Example compound II was prepared by a multistep procedure (procedure given). All the invention compounds were evaluated for their HSL inhibitory activity. From the assay, it was determined that compound II exhibited an IC50 value of 0.04 μM. The experimental process involved the reaction of 1-Benzyl-4-hydroxypiperidine-4-carboxylic acid hydrochloride(cas: 1262988-77-1).HPLC of Formula: 1262988-77-1

The Article related to piperidinecarboxamide preparation hormone sensitive lipase hsl inhibitor treatment disease, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.HPLC of Formula: 1262988-77-1

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Lee, Song Hee et al. published their patent in 2022 |CAS: 1262988-77-1

The Article related to amide compound preparation androgen receptor degradation activity, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Recommanded Product: 1262988-77-1

On January 27, 2022, Lee, Song Hee; Ryu, Je Ho; Ahn, Jung Min; Choi, Yu Ri; Lee, Ho Hyun; Jang, Mi Young; Woo, Yae Jin; Kim, Hanwool; Kim, Ji Young; Park, Ji Youn published a patent.Recommanded Product: 1262988-77-1 The title of the patent was Amide compound for androgen receptor degradation, and pharmaceutical use thereof. And the patent contained the following:

The present invention provides a compound I [R1 = H, alkyl, halogen, etc.; R2 = H, alkyl, halogen, etc.; X1, X3, X4 and X5 = independently CH or N; X2 = CR3 or N; R3 = H, alkyl, halogen, etc.; n = 0, 1, or 2; m = 0 or 1; L = -(CH2)q1-A1-(CH2)q2-B1-(CH2)q3-A2-(CH2)q4-B2-(CH2)q5-A3-(CH2)q6-B3-; A1, A2 and A3 = independently direct bond, -O-, -N(R4)-, etc.; R4 = H, alkyl or haloalkyl; B1, B2 and B3 = independently direct bond, cycloalkyl, heterocycle, etc.; q1-q6 = independently 0-6; E = Q1 or Q2; X6, X7, X8 and X9 = independently CH or N; Y = -C(R6)2-, -C(O)-, -C(R6)2-C(R6′)2-, etc.; Z = direct bond, -C(R6)2-, -O-, etc.; R5 and R5′ = independently H, alkyl, halogen, etc.; R6 and R6′ = independently H, alkyl, halogen, etc.] of a specific chem. structure, having androgen receptor (AR) degradation activity, or a pharmaceutically acceptable salt thereof. The present invention also provides a composition containing the compound or a pharmaceutically acceptable salt thereof. According to present invention, provided is a pharmaceutical use of the compound, the salt thereof, and the composition containing same for treating or preventing AR-related diseases. According to the present invention, further provided is a method for treating or preventing AR-related diseases, the method comprising administering, to a subject in need of treatment, an effective amount of the compound, the salt thereof, or the composition containing same. For example, compound II (preparation given) was coupled with compound III (preparation given) to provide compound IV. The experimental process involved the reaction of 1-Benzyl-4-hydroxypiperidine-4-carboxylic acid hydrochloride(cas: 1262988-77-1).Recommanded Product: 1262988-77-1

The Article related to amide compound preparation androgen receptor degradation activity, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Recommanded Product: 1262988-77-1

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Can You Really Do Chemisty Experiments About 1262988-77-1

Because enzymes can increase reaction rates by enormous factors and tend to be very specific, Safety of 1-Benzyl-4-hydroxypiperidine-4-carboxylic acid hydrochloride, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about 1262988-77-1

Chemistry is the experimental and theoretical study of materials on their properties at both the macroscopic and microscopic levels.In a patent, Safety of 1-Benzyl-4-hydroxypiperidine-4-carboxylic acid hydrochloride, Which mentioned a new discovery about 1262988-77-1

Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein A1, A2, R1, R2, R3 and R4 have the significance given in claim 1.

Because enzymes can increase reaction rates by enormous factors and tend to be very specific, Safety of 1-Benzyl-4-hydroxypiperidine-4-carboxylic acid hydrochloride, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about 1262988-77-1

Reference:
Piperidine – Wikipedia,
Piperidine | C5H21977N – PubChem